Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Queensland Health
Argus Health
Fuji
Citi
Merck
Moodys
Cantor Fitzgerald

Generated: December 18, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ROPIVACAINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Ropivacaine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00130091 The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in Children Completed Children's Hospital of Eastern Ontario Phase 2 The current study will compare the effects on postoperative pain relief of "freezing" (ropivacaine 0.2 %) alone and in combination with clonidine for a nerve block in children undergoing hernia repair. The researchers anticipate that the addition of clonidine to "freezing" will result in prolongation of postoperative pain relief in children undergoing hernia repair compared to "freezing" used alone.
NCT00150865 Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery Completed University Hospital, Angers N/A Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group randomized, includes 30 patients. block performed preoperatively Surgery under general anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine consumption via PCA device. Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.
NCT00197340 Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction Completed International Anesthesia Research Society (IARS) Phase 3 Pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are common and important disorders of pregnancy. Both disorders are associated with an impairment of uteroplacental blood flow (UPBF). No effective therapy has been identified to reliably improve UPBF in these patients and typically, obstetric management involves interventional delivery, particularly problematic when remote from term. This study assess the hypothesis that epidural local anesthetics may improve UPBF in these patients.
NCT00197340 Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction Completed Hadassah Medical Organization Phase 3 Pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are common and important disorders of pregnancy. Both disorders are associated with an impairment of uteroplacental blood flow (UPBF). No effective therapy has been identified to reliably improve UPBF in these patients and typically, obstetric management involves interventional delivery, particularly problematic when remote from term. This study assess the hypothesis that epidural local anesthetics may improve UPBF in these patients.
NCT00210132 Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery Completed Institut Bergonié Phase 2 The purposes of this study are: 1. To determine the efficacy of inter pleural analgesia 2. To determine the plasmatic concentration of ropivacaine by inter pleural road
NCT00289419 Intraarticular Analgesia After Total Hip Arthroplasty, a Randomised Study Completed University of Aarhus Phase 4 The purpose of this study is to determine whether wound infiltration with following single-shot bolus injection with local anesthetic and NASIDs are effective in the treatment of postoperative pain after total hip replacement compared to continuous epidural infusion.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Ropivacaine Hydrochloride

Condition Name

Condition Name for Ropivacaine Hydrochloride
Intervention Trials
Pain, Postoperative 62
Pain 60
Postoperative Pain 59
Total Knee Arthroplasty 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ropivacaine Hydrochloride
Intervention Trials
Pain, Postoperative 154
Osteoarthritis 29
Fractures, Bone 24
Osteoarthritis, Knee 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ropivacaine Hydrochloride

Trials by Country

Trials by Country for Ropivacaine Hydrochloride
Location Trials
United States 140
France 57
Denmark 48
Canada 35
China 33
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ropivacaine Hydrochloride
Location Trials
Ohio 19
California 16
Pennsylvania 13
Texas 11
New York 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ropivacaine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Ropivacaine Hydrochloride
Clinical Trial Phase Trials
Phase 4 219
Phase 3 75
Phase 2/Phase 3 14
[disabled in preview] 53
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ropivacaine Hydrochloride
Clinical Trial Phase Trials
Completed 215
Recruiting 141
Not yet recruiting 87
[disabled in preview] 89
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ropivacaine Hydrochloride

Sponsor Name

Sponsor Name for Ropivacaine Hydrochloride
Sponsor Trials
Zealand University Hospital 9
Yonsei University 8
University of California, San Diego 7
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ropivacaine Hydrochloride
Sponsor Trials
Other 667
Industry 29
U.S. Fed 7
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Fish and Richardson
Deloitte
Harvard Business School
Colorcon
Medtronic
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.